Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1996-09-09
Original market date: See footnote 1
1989-12-31
Product name:
OPTREX PLUS DECONGESTANT EYE DROPS
DIN:
00751316 Electronic product monograph is not available
Company:
OPTREX LABS LTD.
City Wall Howse
Basingstoke
Saone Et Loire
United Kingdom
R621 2JP
Class:
Human
Dosage form(s):
Drops
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
52:32.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01GA51 NAPHAZOLINE, COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0219608001
Active ingredient(s) | Strength |
---|---|
HAMAMELIS VIRGINIANA | 12.5 % |
NAPHAZOLINE HYDROCHLORIDE | 0.01 % |